The drug information residency is a specialized program consisting of 12 months of training designed to develop an advanced practitioner in the provision of medical information and policy development. The residency program provides opportunities to participate in numerous activities that a medical information specialist encounters in an industrial and hospital setting, as well as diverse clinical exposures. The resident will work with established pharmacy clinicians on interdisciplinary teams throughout Duke University Hospital and GlaxoSmithKline. The resident spends 6 months training at the GSK Medical Information Department at the Research Triangle Park, NC campus and 6 months with the Center for Medication Policy at DUH. Upon completion of this program, the resident will have the experience and clinical skills necessary to practice as a drug information specialist in a variety of settings.
The purpose of the Residency Program is to prepare the resident to practice as a drug information specialist in an area of interest to the resident. Practice excellence will be achieved by:
· Demonstrating accountability for patient focused project work
· Modeling excellence in drug information practice
· Participating in research and performance improvement projects focused on clinical care and improving the medication use process
· Demonstrating the ability to collaborate with healthcare professionals to communicate key information and guide decision making
· Facilitating, leading, and actively participating in discussions and committees important to the role of a hospital and industry drug information practitioner
· Serving as a professional role model for others in training
· Serve as an authoritative resource on the formulary management process
· Guide the development of recommendations that serve to optimize a health system formulary
· Provide evidence-based, patient-centered medication therapy recommendations during drug information consults
· Make recommendations to optimize the use of medications by participating in the medication use evaluation process
· Make recommendations to optimize drug information content in promotional materials
· Participate in activities that drive development of action plans during medication shortages
· Participate in the development of medication policy
· Demonstrate excellence in the provision of training or educational activities for health care professionals and health care professionals in training.
· Actively participate in the analysis and investigation of adverse drug event reporting
· Complete required rotations
· Conduct drug information and/or pharmacy practice research
· Function effectively in hospital and industry settings
· Publish on topics related to the practice of pharmacy or drug information
The Drug Information Residency does not utilize the Phorcas Application Process.
The application should include a letter of interest, curriculum vitae, and three letters of recommendation. Application materials for the Duke University Hospital Specialty Residency in Drug Information must be sent electronically.
Applications should be sent to the following address by December 15th: